Latest news with #Omada
CNBC
5 days ago
- Business
- CNBC
Omada Health aims to go public with market cap of up to $1.1 billion
Omada Health plans to raise up to $158 million in its up coming IPO, attaining a market cap of about $1.1 billion at the top end of its expected range, according to a filing on Thursday. The virtual chronic care company filed its prospectus earlier this month, and has just updated the filing with an expected pricing range of $18 to $20 per share. Omada said it plans to sell 7.9 million shares in the offering. The size of the offering and share price could change, and the market cap could be higher on a fully diluted bases. The IPO is expected to take place next week. Omada, which offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension, will be the second digital health company to hit the market in a matter of weeks after an extended drought. Digital physical therapy startup Hinge Health debuted on the New York Stock Exchange earlier this month. Omada, based in San Francisco, describes its approach as a "between-visit care model" that is complementary to the broader health-care ecosystem, according to its prospectus. Sean Duffy, Omada's CEO, co-founded the company in 2012 with Andrew DiMichele and Adrian James, who have both moved on to other ventures. Omada's revenue increased 57% in its first quarter to $55 million from $35.1 million a year earlier, the filing said. For 2024, revenue rose 38% to $169.8 million from $122.8 million the previous year. The company's net loss narrowed to $9.4 million in the first quarter from $19 million a year ago. "To our prospective shareholders, thank you for learning more about Omada," Duffy said in the prospectus. I invite you to join our journey." The company will trade on the Nasdaq under the ticker symbol "OMDA." Morgan Stanley, Goldman Sachs and JPMorgan Chase are leading the offering. Omada's top shareholders are U.S. Venture Partners, Andreessen Horowitz and Fidelity.
Yahoo
6 days ago
- Business
- Yahoo
Omada Health targets valuation of over $1 billion in US IPO
(Reuters) -Virtual chronic care provider Omada Health is targeting a valuation of about $1.1 billion in its initial public offering in the United States, signaling a comeback for capital markets after several months of slowdown in listings. The company said on Thursday it would sell 7.9 million shares in a range of $18 to $20 per share, potentially fetching up to $158 million if priced at the upper limit. While U.S. President Donald Trump's tariff whiplash has roiled markets and cast a shadow on new listings, companies in sectors perceived as less sensitive to economic headwinds are pushing ahead with their initial public offerings. The San Francisco, California-based company, last raised $192 million in a Series E funding round in 2022. Omada has applied to list its common stock on the Nasdaq under the symbol "OMDA". Goldman Sachs, Morgan Stanley and Barclays are among the underwriters for Omada's offering.
Yahoo
6 days ago
- Business
- Yahoo
Omada Health targets valuation of over $1 billion in US IPO
(Reuters) -Virtual chronic care provider Omada Health is targeting a valuation of about $1.1 billion in its initial public offering in the United States, signaling a comeback for capital markets after several months of slowdown in listings. The company said on Thursday it would sell 7.9 million shares in a range of $18 to $20 per share, potentially fetching up to $158 million if priced at the upper limit. While U.S. President Donald Trump's tariff whiplash has roiled markets and cast a shadow on new listings, companies in sectors perceived as less sensitive to economic headwinds are pushing ahead with their initial public offerings. The San Francisco, California-based company, last raised $192 million in a Series E funding round in 2022. Omada has applied to list its common stock on the Nasdaq under the symbol "OMDA". Goldman Sachs, Morgan Stanley and Barclays are among the underwriters for Omada's offering. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
Omada Health Announces Launch of Initial Public Offering
SAN FRANCISCO, May 29, 2025--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, announced today that it has launched the roadshow for its proposed initial public offering of its common stock. Omada Health has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") to offer an aggregate of 7,900,000 shares of its common stock. In addition, Omada Health intends to grant the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $18.00 and $20.00 per share. Omada Health has applied to list its common stock on the Nasdaq Global Market under the ticker symbol "OMDA." Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Needham & Company are acting as co-managers for the proposed offering. The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at prospectus@ Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316, or by email at prospectus-ny@ or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus-eq_fi@ and postsalemanualrequests@ A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Omada Health Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada's scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s. View source version on Contacts Rose Ramsethpress@ Allan KellsIR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
6 days ago
- Business
- Business Wire
Omada Health Announces Launch of Initial Public Offering
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, announced today that it has launched the roadshow for its proposed initial public offering of its common stock. Omada Health has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the 'SEC') to offer an aggregate of 7,900,000 shares of its common stock. In addition, Omada Health intends to grant the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $18.00 and $20.00 per share. Omada Health has applied to list its common stock on the Nasdaq Global Market under the ticker symbol 'OMDA.' Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Needham & Company are acting as co-managers for the proposed offering. The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at prospectus@ Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316, or by email at prospectus-ny@ or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus-eq_fi@ and postsalemanualrequests@ A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Omada Health Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada's scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.
